Copyright
©2012 Baishideng Publishing Group Co.
World J Cardiol. May 26, 2012; 4(5): 135-147
Published online May 26, 2012. doi: 10.4330/wjc.v4.i5.135
Published online May 26, 2012. doi: 10.4330/wjc.v4.i5.135
Table 1 Classification of blood pressure for adults according to JNC-7
| Classification | SBP (mmHg) | DBP (mmHg) |
| Normal | ≤ 120 | And ≤ 80 |
| Prehypertension | 120-139 | Or 80-89 |
| Stage 1 hypertension | 140-159 | Or 90-99 |
| Stage 2 hypertension | ≥ 160 | Or ≥ 100 |
Table 2 Classification of blood pressure for adults according to ESH/ESC 2007
| Classification | SBP (mmHg) | DBP (mmHg) |
| Οptimal | ≤ 120 | And ≤ 80 |
| Normal | 120-129 | 80-84 |
| High normal | 130-139 | 85-89 |
| Hypertension | ||
| Grade 1 (mild) | 140-159 | 90-99 |
| Grade 2 (moderate) | 160-179 | 100-109 |
| Grade 3 (severe) | ≥ 180 | ≥ 100 |
| Isolated systolic hypertension | ≥ 140 | ≤ 90 |
Table 3 Causes of secondary hypertension
| Hyperaldosteronism |
| Cushing syndrome |
| Coarctation of the aorta |
| Renovascular stenosis |
| Endocrine disorders (thyroid, parathyroid abnormalities) |
| Obstructive sleep apnea |
| Drugs (nonsteroidal antiinflammatory drugs, alcohol, estrogen) |
| Chronic kidney disease |
| Pheochromocytoma |
Table 4 Causes of resistant hypertension
| False positive or pseudoresistance |
| Incorrect technique in measuring blood pressure |
| Pseudohypertension |
| Lack of adherence to life style modifications |
| Lack of patient adherence to antihypertensive therapy |
| Suboptimal therapy |
| True resistant hypertension |
| Sleep apnea |
| Hypertension related to secondary etiology |
Table 5 Therapeutic strategies
| Non-pharmacological strategy |
| Weight reduction |
| Dietary sodium reduction |
| Physical activity |
| Moderate alcohol consumption |
| Dash diet |
| Pharmacological strategy |
| Main Pharmacological agents |
| Thiazide diuretic: inhibiting reabsorption of sodium (Na+) and chloride (Cl-) ions from the distal convoluted tubules in the kidneys →→↓ BP, ↓ stroke, ↓ CV mortality |
| ACEIs: block the conversion of angiotensin I to angiotensin II →→↓ SVR, ↓ BP, ↓ mortality in patients with MI and left ventricular dysfunction, ↓ progression of diabetic renal disease |
| ARBs: direct blockage of angiotensin II receptors →→ vasodilation (↓SVR), ↓ secretion of vasopressin, ↓ aldosterone, ↓ BP, ↓ stroke. Generally, in patients who cannot tolerate ACEs |
| Calcium antagonists: disrupts the movement of calcium through calcium channels in cardiac muscle and peripheral arteries →→ vasodilation (↓ SVR), ↓ BP, ↓ CV complications in elderly patients with ISH |
| β blockers: ↓ heart rate, ↓ cardiac contractility, ↓ cardiac output, inhibit renin release, ↑ nitric oxide, ↓ vasomotor tone →→↓ BP |
| Other agents: direct renin inhibitors, aldosterone receptor antagonists, centrally acting agents, direct vasodilators, α-adrenergic blocking agents |
| Combination therapy |
| ACEIs or ARBs/Diuretic |
| ACEIs or ARBs/Calcium antagonist (especially in patients with high CV risk) |
- Citation: Lionakis N, Mendrinos D, Sanidas E, Favatas G, Georgopoulou M. Hypertension in the elderly. World J Cardiol 2012; 4(5): 135-147
- URL: https://www.wjgnet.com/1949-8462/full/v4/i5/135.htm
- DOI: https://dx.doi.org/10.4330/wjc.v4.i5.135
